Goldenwell Biotech (GWLL) Other Operating Expenses (2020 - 2023)

Goldenwell Biotech has reported Other Operating Expenses for 3 years, with the latest figure at -$68634.0 in Q1 2023.

• For the quarter ending Q1 2023, Other Operating Expenses changed N/A year-over-year to -$68634.0; the trailing twelve-month figure through Dec 2023 stood at -$68634.0 (changed N/A YoY), and the FY2021 full-year result was -$253310.0, changed N/A from the prior year.
• Other Operating Expenses for Q1 2023 stood at -$68634.0, up from -$253310.0 in the prior quarter.
• The five-year high for Other Operating Expenses was -$292.0 in Q2 2020, with the low at -$253310.0 in Q4 2021.
• Historically, Other Operating Expenses has averaged -$92959.2 across 3 years, with a median of -$68634.0 in 2023.
• The largest YoY upside for Other Operating Expenses was 16632.19% in 2021 against a maximum downside of 16632.19% in 2021.
• Goldenwell Biotech's Other Operating Expenses stood at -$292.0 in 2020, then plunged by 86650.0% to -$253310.0 in 2021, then soared by 72.91% to -$68634.0 in 2023.
• The last three Other Operating Expenses figures came in at -$68634.0 (Q1 2023), -$253310.0 (Q4 2021), and -$48858.0 (Q2 2021), per Business Quant data.